Argus Investors' Counsel, Inc. Zoetis Inc. Transaction History

Argus Investors' Counsel, Inc.

$148 Million
Q3 2024

A detailed history of Argus Investors' Counsel, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Argus Investors' Counsel, Inc. holds 4,788 shares of ZTS stock, worth $847,284. This represents 0.63% of its overall portfolio holdings.

Number of Shares

4,788

Previous 6,653 28.03%

Holding current value

$847,284

Previous $1.15 Million 18.91%

% of portfolio

0.63%

Previous 0.72%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$172.58 - $196.48 $321,861 - $366,435	-1,865 Reduced 28.03%	4,788 $935,000
Q2 2024 Jul 22, 2024	BUY	$145.54 - $178.83 $968,277 - $1.19 Million	6,653 New	6,653 $1.15 Million
Q1 2024 Apr 24, 2024	SELL	$165.67 - $199.94 $242,706 - $292,912	-1,465 Reduced 15.0%	8,299 $1.4 Million
Q4 2023 Jan 26, 2024	BUY	$151.44 - $200.09 $908 - $1,200	6 Added 0.06%	9,764 $1.93 Million
Q4 2023 Jan 19, 2024	SELL	$151.44 - $200.09 $4,543 - $6,002	-30 Reduced 0.31%	9,758 $1.93 Million
Q3 2023 Oct 17, 2023	SELL	$167.14 - $192.77 $51,813 - $59,758	-310 Reduced 3.07%	9,788 $1.7 Million
Q2 2023 Jul 20, 2023	BUY	$160.94 - $186.23 $29,452 - $34,080	183 Added 1.85%	10,098 $1.74 Million
Q4 2022 Jan 18, 2023	SELL	$131.14 - $157.47 $124,582 - $149,596	-950 Reduced 8.74%	9,915 $0
Q3 2022 Oct 18, 2022	SELL	$148.29 - $182.55 $322,827 - $397,411	-2,177 Reduced 16.69%	10,865 $1.61 Million
Q2 2022 Jul 22, 2022	BUY	$155.97 - $200.09 $37,900 - $48,621	243 Added 1.9%	13,042 $2.24 Million
Q1 2022 May 04, 2022	BUY	$181.39 - $234.03 $325,413 - $419,849	1,794 Added 16.3%	12,799 $2.41 Million
Q4 2021 Jan 25, 2022	SELL	$193.69 - $247.03 $314,746 - $401,423	-1,625 Reduced 12.87%	11,005 $2.69 Million
Q3 2021 Oct 20, 2021	SELL	$189.29 - $209.69 $2.04 Million - $2.26 Million	-10,762 Reduced 46.01%	12,630 $2.45 Million
Q2 2021 Jul 30, 2021	SELL	$155.9 - $187.99 $412,043 - $496,857	-2,643 Reduced 10.15%	23,392 $4.36 Million
Q1 2021 Apr 19, 2021	BUY	$144.0 - $169.39 $63,360 - $74,531	440 Added 1.72%	26,035 $4.1 Million
Q4 2020 Jan 27, 2021	SELL	$157.07 - $174.35 $1.02 Million - $1.13 Million	-6,503 Reduced 20.26%	25,595 $4.24 Million
Q3 2020 Oct 30, 2020	BUY	$137.1 - $165.37 $154,648 - $186,537	1,128 Added 3.64%	32,098 $5.31 Million
Q2 2020 Jul 27, 2020	SELL	$111.92 - $142.53 $2,798 - $3,563	-25 Reduced 0.08%	30,970 $4.24 Million
Q1 2020 Apr 24, 2020	SELL	$92.66 - $144.94 $69,495 - $108,705	-750 Reduced 2.36%	30,995 $3.65 Million
Q4 2019 Jan 17, 2020	SELL	$116.25 - $133.25 $156,937 - $179,887	-1,350 Reduced 4.08%	31,745 $4.2 Million
Q3 2019 Oct 17, 2019	SELL	$112.57 - $128.43 $978,233 - $1.12 Million	-8,690 Reduced 20.8%	33,095 $4.12 Million
Q2 2019 Jul 10, 2019	BUY	$97.98 - $114.28 $3.88 Million - $4.52 Million	39,585 Added 90.0%	83,570 $9.48 Million
Q2 2019 Jul 10, 2019	SELL	$97.98 - $114.28 $4.09 Million - $4.78 Million	-41,785 Reduced 50.0%	41,785 $4.74 Million
Q1 2019 Apr 16, 2019	SELL	$81.56 - $100.67 $433,246 - $534,759	-5,312 Reduced 10.78%	43,985 $4.43 Million
Q4 2018 Feb 06, 2019	SELL	$79.28 - $95.27 $441,986 - $531,130	-5,575 Reduced 10.16%	49,297 $4.22 Million
Q3 2018 Oct 16, 2018	SELL	$83.5 - $93.23 $180,360 - $201,376	-2,160 Reduced 3.79%	54,872 $0
Q2 2018 Jul 19, 2018	SELL	$79.9 - $89.2 $667,564 - $745,266	-8,355 Reduced 12.78%	57,032 $4.86 Million
Q1 2018 May 15, 2018	BUY	$71.51 - $84.69 $64,001 - $75,797	895 Added 1.39%	65,387 $4.17 Million
Q4 2017 Jan 23, 2018	SELL	$63.24 - $72.8 $56,599 - $65,156	-895 Reduced 1.37%	64,492 $4.65 Million
Q3 2017 Oct 06, 2017	BUY	$59.73 - $65.4 $3.91 Million - $4.28 Million	65,387	65,387 $4.17 Million

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.

Account

Argus Investors' Counsel, Inc. Zoetis Inc. Transaction History